B Andersson

2.0k total citations
39 papers, 1.5k citations indexed

About

B Andersson is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, B Andersson has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in B Andersson's work include Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (6 papers). B Andersson is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (6 papers). B Andersson collaborates with scholars based in United States, United Kingdom and Sweden. B Andersson's co-authors include Sergio Giralt, Issa F. Khouri, Richard E. Champlin, Örjan Wränge, Jan-Ακε Gustafsson, A C Wikström, Sam Okret, Peter F. Thall, Vickie R. Shannon and Kristen Price and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

B Andersson

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Andersson United States 20 616 478 327 317 214 39 1.5k
Michael Koenigsmann Germany 20 405 0.7× 436 0.9× 296 0.9× 165 0.5× 185 0.9× 63 1.5k
John H. Saiki United States 17 274 0.4× 568 1.2× 329 1.0× 180 0.6× 149 0.7× 29 1.4k
Nathan L. Kobrinsky United States 20 1.1k 1.8× 282 0.6× 167 0.5× 305 1.0× 269 1.3× 58 2.0k
Lawrence S. Lessin United States 25 421 0.7× 630 1.3× 117 0.4× 192 0.6× 458 2.1× 61 2.0k
David L. Becton United States 26 852 1.4× 335 0.7× 221 0.7× 83 0.3× 321 1.5× 61 1.9k
Sanna Siitonen Finland 23 226 0.4× 354 0.7× 324 1.0× 125 0.4× 103 0.5× 51 1.4k
E Damasio Italy 23 552 0.9× 417 0.9× 297 0.9× 434 1.4× 472 2.2× 65 1.5k
Matthew J. Olnes United States 18 890 1.4× 352 0.7× 260 0.8× 89 0.3× 262 1.2× 42 1.6k
Senji Kasahara Japan 21 236 0.4× 434 0.9× 260 0.8× 425 1.3× 171 0.8× 85 1.3k
Shinjiro Todo Japan 21 721 1.2× 236 0.5× 444 1.4× 91 0.3× 88 0.4× 79 1.4k

Countries citing papers authored by B Andersson

Since Specialization
Citations

This map shows the geographic impact of B Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Andersson more than expected).

Fields of papers citing papers by B Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Andersson. The network helps show where B Andersson may publish in the future.

Co-authorship network of co-authors of B Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of B Andersson. A scholar is included among the top collaborators of B Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Andersson. B Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andersson, B, S. Lundin, Sophie Lindgren, O. Stenqvist, & Helena Odenstedt Hergès. (2010). End-expiratory lung volume and ventilation distribution with different continuous positive airway pressure systems in volunteers. Acta Anaesthesiologica Scandinavica. 55(2). 157–164. 15 indexed citations
2.
Couriel, Daniel R., Rima M. Saliba, Marcos de Lima, et al.. (2009). A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 15(12). 1555–1562. 84 indexed citations
4.
Uhlin, Fredrik, Bengt Ekermo, B. Isaksson, et al.. (2003). Perspectives on Hepatitis B Infections and the Efficacy of Vaccination (Hepatitis B and Pneumococci) in Dialysis Patients. Upsala Journal of Medical Sciences. 108(1). 61–74. 2 indexed citations
5.
Hortobagyi, Gabriel N., Aman U. Buzdar, Richard L. Theriault, et al.. (2000). Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma. JNCI Journal of the National Cancer Institute. 92(3). 225–233. 126 indexed citations
6.
Przepiorka, Donna, Koen van Besien, Brian L. Samuels, et al.. (1999). Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma. Annals of Oncology. 10(5). 527–529. 38 indexed citations
7.
Price, Kristen, Peter F. Thall, Susannah K. Kish, Vickie R. Shannon, & B Andersson. (1998). Prognostic Indicators for Blood and Marrow Transplant Patients Admitted to an Intensive Care Unit. American Journal of Respiratory and Critical Care Medicine. 158(3). 876–884. 136 indexed citations
8.
Ippoliti, Cindy, Amy Morgan, Koen van Besien, et al.. (1997). Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir. Bone Marrow Transplantation. 20(6). 491–495. 18 indexed citations
9.
Besien, Koen van, Donna Przepiorka, Rakesh Mehra, et al.. (1996). Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies.. Journal of Clinical Oncology. 14(11). 3036–3042. 30 indexed citations
10.
Anaissie, E., Dimitrios P. Kontoyiannis, S. E. Vartivarian, et al.. (1993). Effectiveness of an Oral Triazole for Opportunistic Mold Infections in Patients with Cancer: Experience with SCH 39304. Clinical Infectious Diseases. 17(6). 1022–1031. 20 indexed citations
12.
13.
Andersson, B. (1990). Chemopurging of leukemic marrow in conjunction with autologous bone marrow transplantation. 42(3). 185–193. 1 indexed citations
14.
Busch, Christian, et al.. (1990). Influence of Blood Group Type on Prognosis ofTransitional Cell Carcinoma of the Urinary Bladder. European Urology. 18(2). 97–100. 3 indexed citations
15.
Dreizen, Samuel, Kenneth B. McCredie, Michael J. Keating, & B Andersson. (1990). Nutritional deficiencies in patients receiving cancer chemotherapy. Postgraduate Medicine. 87(1). 163–170. 48 indexed citations
16.
Ling, Yi‐He, B Andersson, & J. Arly Nelson. (1990). DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.. PubMed. 11(1). 23–30. 16 indexed citations
17.
Andersson, B, et al.. (1990). Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia. Cancer. 65(5). 1079–1084. 57 indexed citations
18.
Childs, Craig C., C Hirsch-Ginsberg, R S Walters, et al.. (1989). Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics.. PubMed. 3(11). 777–83. 54 indexed citations
19.
Andersson, B, et al.. (1988). Role of adherence of Streptococcus pneumoniae in acute otitis media. The Pediatric Infectious Disease Journal. 7(7). 476–479. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026